Travere Therapeutics, Inc. (TVTX)

47.32 -1.25 (-2.57%) USD  |  NASDAQ  |  Jun 10, 15:25
More

Travere Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for TVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Inovio Pharmaceuticals, Inc. Upgrade
Insmed, Inc. Upgrade